Evidence map›Paper›PMID 41107827›Full record

ArticleBMC medical imaging2025

Multiparametric MRI assessment of acute neuroinflammation in a murine model of peripheral LPS stimulation.

Derya R Shimshek, Stefan Zurbruegg, Anna Neuhaus, Anna Schubart, Fabrizio Gasparini, Nicolau Beckmann

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Derya R ShimshekNeurosciences, Novartis Biomedical Research, Basel, CH-4056, Switzerland.
Stefan ZurbrueggNeurosciences, Novartis Biomedical Research, Basel, CH-4056, Switzerland.
Anna NeuhausNeurosciences, Novartis Biomedical Research, Basel, CH-4056, Switzerland.
Anna SchubartImmunology, Novartis Biomedical Research, Basel, CH-4056, Switzerland.
Fabrizio GaspariniNeurosciences, Novartis Biomedical Research, Basel, CH-4056, Switzerland.
Nicolau BeckmannDiseases of Aging & Regenerative Medicine, Novartis Biomedical Research, Basel, CH-4056, Switzerland. nicolau.beckmann@novartis.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuroinflammation is implicated in the pathogenesis of several central nervous system disorders. Excessive and prolonged neuroinflammation impacts disease progression and potential interventions. A widely used model of peripherally-induced neuroinflammation involves the intraperitoneal administration of the endotoxin lipopolysaccharide (LPS) to mice. In this exploratory study, magnetic resonance imaging (MRI) was used to non-invasively investigate in the brain acute neuroinflammation induced by peripheral LPS stimulation and in combination with the microglia depleting effects of the colony stimulating factor 1 receptor kinase inhibitor BLZ945.

methodsMultiparametric MRI, including T

resultsOn day 4 of LPS administration, T

conclusionThe present findings highlight the potential of non-contrast-enhanced MRI to assess acute neuroinflammation-related changes in several mouse brain areas upon peripheral LPS stimulation. The assessment of multiple parameters provided sufficient sensitivity to detect pharmacological modulation of the neuroinflammatory response elicited by the endotoxin.

Indexed as

BrainLipopolysaccharidesMultiparametric Magnetic Resonance ImagingNeuroinflammatory DiseasesAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMicrogliaLipopolysaccharidesAstrocyteColony stimulating factor-1 (CSF-1)ImagingLipopolysaccharide (LPS)Magnetic resonance imaging (MRI)MicrogliaNeuroinflammation

Identifiers

PMID41107827
PMCPMC12535063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.